In accordance with these findings, several studies focused on AD research have demonstrated that Aβ can enhance mTOR signaling, while rapamycin and its analogs, which act as mTOR complex 1 (mTORC1) inhibitors, significantly reduce intracellular Aβ levels [41,69,70,71]. The gene discussed is MTOR; the disease is Alzheimer disease.